Mark A Scheideler Selected Research

Mark A Scheideler Research Topics

3	Neuralgia (Stump Neuralgia) 01/2005 - 03/2003
3	Hyperalgesia 02/2004 - 03/2003
2	Pain (Aches) 02/2004 - 03/2003
1	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 01/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2018
1	Chronic Pain 02/2004
1	Acute Pain 12/2003
1	Ataxia (Dyssynergia) 12/2003
1	Nociceptive Pain 12/2003
1	Ischemia 05/2002
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 05/2002
1	Brain Infarction 05/2002

2	Opioid Analgesics (Opioids)IBA 02/2004 - 12/2003
2	CarrageenanIBA 02/2004 - 12/2003
1	Antisense OligonucleotidesIBA 01/2018
1	Myelin ProteinsIBA 01/2018
1	NociceptinIBA 02/2004
1	cis- 1- methyl- 7- ((4- (2,6- dichlorophenyl)piperidin- 1- yl)methyl)- 6,7,8,9- tetrahydro- 5H- benzocyclohepten- 5- olIBA 02/2004
1	delta Opioid Receptors (delta Opioid Receptor)IBA 12/2003
1	kappa Opioid Receptors (kappa Opioid Receptor)IBA 12/2003
1	isoquinolineIBA 12/2003
1	Opioid Receptors (Opioid Receptor)IBA 03/2003
1	Messenger RNA (mRNA)IBA 03/2003
1	Morphine (MS Contin)FDA LinkGeneric 03/2003
1	Protein Isoforms (Isoforms)IBA 03/2003
1	GTP-Binding Proteins (G-Protein)IBA 03/2003
1	3-methyl-aminothiophene dicarboxylic acidIBA 05/2002

3	Ligation 01/2005 - 03/2003
1	Therapeutics 02/2004